Senate Prevails On PDUFA Antibiotic Incentive As House Vote Nears
This article was originally published in The Pink Sheet Daily
Executive Summary
House is expected to vote on the reconciled FDA user fee bill June 20. Negotiators picked Senate GAIN language, including its less prescriptive qualifying pathogen definition.